JP3226174B2 - ３，４−ジヒドロ−２ｈ−１−ベンゾピラン類のヒドラジド誘導体類 - Google Patents

３，４−ジヒドロ−２ｈ−１−ベンゾピラン類のヒドラジド誘導体類

Info

Publication number
JP3226174B2
JP3226174B2 JP51746693A JP51746693A JP3226174B2 JP 3226174 B2 JP3226174 B2 JP 3226174B2 JP 51746693 A JP51746693 A JP 51746693A JP 51746693 A JP51746693 A JP 51746693A JP 3226174 B2 JP3226174 B2 JP 3226174B2
Authority
JP
Japan
Prior art keywords
alkyl
compound according
compound
dihydro
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP51746693A
Other languages
English (en)
Japanese (ja)
Other versions
JPH07505625A (ja
Inventor
グリサル，ジェイ．マーティン
エイ． ペティー，マーガレット
ボルケニウス，フランク
Original Assignee
メレルダウファーマスーティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メレルダウファーマスーティカルズ インコーポレイテッド filed Critical メレルダウファーマスーティカルズ インコーポレイテッド
Publication of JPH07505625A publication Critical patent/JPH07505625A/ja
Application granted granted Critical
Publication of JP3226174B2 publication Critical patent/JP3226174B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
JP51746693A 1992-04-07 1993-03-12 ３，４−ジヒドロ−２ｈ−１−ベンゾピラン類のヒドラジド誘導体類 Expired - Fee Related JP3226174B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92400972.3 1992-04-07
EP92400972 1992-04-07
PCT/US1993/002311 WO1993020059A1 (en) 1992-04-07 1993-03-12 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans

Publications (2)

Publication Number Publication Date
JPH07505625A JPH07505625A (ja) 1995-06-22
JP3226174B2 true JP3226174B2 (ja) 2001-11-05

Family

ID=8211648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51746693A Expired - Fee Related JP3226174B2 (ja) 1992-04-07 1993-03-12 ３，４−ジヒドロ−２ｈ−１−ベンゾピラン類のヒドラジド誘導体類

Country Status (19)

Country Link
EP (1) EP0635011B1 (enExample)
JP (1) JP3226174B2 (enExample)
KR (1) KR950700680A (enExample)
AT (1) ATE146466T1 (enExample)
AU (1) AU675784B2 (enExample)
CA (1) CA2132831C (enExample)
DE (1) DE69306770T2 (enExample)
DK (1) DK0635011T3 (enExample)
ES (1) ES2098730T3 (enExample)
FI (1) FI944678A7 (enExample)
GR (1) GR3022122T3 (enExample)
HU (1) HU215912B (enExample)
IL (1) IL105319A (enExample)
MX (1) MX9301979A (enExample)
NO (1) NO943760L (enExample)
NZ (1) NZ251174A (enExample)
TW (1) TW278076B (enExample)
WO (1) WO1993020059A1 (enExample)
ZA (1) ZA932414B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010505A1 (de) * 1980-03-19 1981-10-01 Basf Ag, 6700 Ludwigshafen Chromanderivate, verfahren zu ihrer herstellung, ihre verwendung als stabilisatoren von organischen materialien sowie diese stabilisatoren enthaltende organische materialien
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
EP0369083A1 (en) * 1988-11-14 1990-05-23 Merrell Dow Pharmaceuticals Inc. Cardioprotective tocopherol analogs
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터

Also Published As

Publication number Publication date
EP0635011B1 (en) 1996-12-18
FI944678A0 (fi) 1994-10-06
WO1993020059A1 (en) 1993-10-14
CA2132831A1 (en) 1993-10-14
DE69306770D1 (de) 1997-01-30
JPH07505625A (ja) 1995-06-22
HU215912B (hu) 1999-03-29
DE69306770T2 (de) 1997-06-12
NZ251174A (en) 1996-01-26
TW278076B (enExample) 1996-06-11
MX9301979A (es) 1993-11-01
ZA932414B (en) 1993-10-22
GR3022122T3 (en) 1997-03-31
IL105319A (en) 1998-02-22
ES2098730T3 (es) 1997-05-01
AU675784B2 (en) 1997-02-20
HUT68833A (en) 1995-08-28
HU9402882D0 (en) 1995-01-30
DK0635011T3 (da) 1997-01-06
EP0635011A1 (en) 1995-01-25
NO943760L (no) 1994-12-06
FI944678L (fi) 1994-10-06
FI944678A7 (fi) 1994-10-06
ATE146466T1 (de) 1997-01-15
AU3807293A (en) 1993-11-08
NO943760D0 (no) 1994-10-06
KR950700680A (ko) 1995-02-20
IL105319A0 (en) 1993-08-18
CA2132831C (en) 1998-06-16

Similar Documents

Publication Publication Date Title
JP3230699B2 (ja) 心臓保護トコフェロ−ル類似体
JP3066901B2 (ja) 心臓保護トコフェロール類似体
JP3226185B2 (ja) 組織保護トコフェロ−ル類似体
JP3226174B2 (ja) ３，４−ジヒドロ−２ｈ−１−ベンゾピラン類のヒドラジド誘導体類
US5545660A (en) Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
JP3246741B2 (ja) ２，３−ジヒドロベンゾフラノールの新規な誘導体及びその製法
JP3248183B2 (ja) 新規な心臓保護剤
JPH11501655A (ja) ２，３−ジヒドロ−ベンゾフラノール誘導体の新規な製造法
EP0463944A1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US5500444A (en) Cardioprotective tocopherol analogs
US5510373A (en) Cardioprotective agents
JP2574052B2 (ja) アスコルビン酸誘導体、その製法およびその用途
CN115448915A (zh) 一种sirt5抑制剂及其制备方法和用途

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080831

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080831

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090831

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090831

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100831

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110831

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110831

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120831

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees